TLP
PRAX icon

Tri Locum Partners’s Praxis Precision Medicines PRAX Stock Holding History

Tri Locum Partners’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75,986
Closed -$4.03M – 21
2025
Q3 		$4.03M Sell
75,986
-119,446
-61% -$5.79M 0.93% 17
2025
Q2 		$8.22M Buy
195,432
+111,773
+134% +$4.26M 2.49% 15
2025
Q1 		$3.17M Buy
83,659
+46,390
+124% +$2.9M 1.63% 20
2024
Q4 		$2.87M Buy
+37,269
New +$2.7M 0.59% 27
2024
Q3 		– Sell
-75,319
Closed -$3.12M – 25
2024
Q2 		$3.12M Sell
75,319
-31,175
-29% -$1.47M 0.79% 22
2024
Q1 		$6.5M Sell
106,494
-142,267
-57% -$6.38M 2.25% 17
2023
Q4 		$5.54M Sell
248,761
-74,958
-23% -$1.35M 2.53% 17
2023
Q3 		$8.3M Sell
323,719
-1,922
-0.6% -$36.4K 2.65% 13
2023
Q2 		$5.62M Buy
325,641
+159,751
+96% +$2.45M 2.09% 21
2023
Q1 		$2.01M Buy
165,890
+164,280
+10,204% +$6.93M 0.61% 38
2022
Q4 		$57K Buy
+1,610
New +$50.2K 0.02% 53

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Tri Locum Partners's PRAX Position: Q4 2025 in Review

Tri Locum Partners sold out of Praxis Precision Medicines (PRAX) in Q4 2025, closing a stake of 75,986 shares — an estimated $4.03M sold.

Tri Locum Partners first reported a position in PRAX in Q4 2022 and held it in 11 quarters. The position peaked at $8.3M in Q3 2023. 250 funds tracked by Wall St. Rank hold PRAX as of Q4 2025.

  • Tri Locum Partners reported no remaining Praxis Precision Medicines position as of Q4 2025 after selling out during the quarter.
  • Tri Locum Partners sold 75,986 Praxis Precision Medicines shares in Q4 2025, an estimated $4.03M.
  • Tri Locum Partners first reported a position in Praxis Precision Medicines in Q4 2022 and held it in 11 quarters.
  • Tri Locum Partners's Praxis Precision Medicines position peaked at $8.3M in Q3 2023.
  • 250 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q4 2025.

Based on Tri Locum Partners's 13F filing for Q4 2025, filed 17 Feb 2026.